CD4 and polyp: Taken together, this suggested that treatments associated with decreased polyp burden resulted in more activated CD4 and CD8 T cells and fewer macrophages in polyps, and further that there was a shift from anti-inflammatory toward pro-inflammatory macrophages in the spleen.